Taylor & Francis

We spoke to Mark Behlke, the chief scientific officer of Integrated DNA Technologies (IA, USA), about the current limitations of CRISPR/Cas9 techniques and the potential of the novel HiFI Cas9 enzyme to resolve these limitations, as shown in a sickle cell disease-causing mutation.

In line with our October focus on healthcare-associated infections, we spoke to Amy Mathers about her research on the role of hospital plumbing in the evolution and exchange of genes of drug resistance.

Amy discussed her research on sink traps, toilets and wastewater, what solutions hospitals can use and antibiotic resistance in the broader context – including the role of infection prevention and control.

Find out more about the flow cytometry in this Bioanalysis Zone interview with Christoph Eberle (Charles River Laboratories), as part of our 'In the Zone' feature. You can find out more about flow cytometry on the website, at: http://bit.ly/2RuwAKi

In this podcast, Roshaine Wijayatunga, Senior Editor for Oncology at Future Science Group speaks with Barbara Moss, a Patient Ambassador for Europacolon (UK) and Bowel Cancer UK.

At the age of 52, in 2006, Barbara was diagnosed with Stage IV colorectal cancer of the colon, spread to the liver, and was told she had 3–5 months to live. Barbara is now an active campaigner and an active member of several organizations in the UK and Europe. Her main wish is for patients to be able to access the medicine that they need, to have choices clearly explained and to be treated personally.

Since Zika broke into the news in 2016, new research has been uncovering more information about this virus – we spoke to Dustin Farr at the recent ASM Microbe meeting where he was presenting a poster on Zika infection in corneal cells.

Find out more about the technologies utilized in drug discovery and what the future holds for biotherapeutic drug metabolism studies in this Bioanalysis Zone interview with Kevin Ray (MilliporeSigma), as part of our 'In the Zone' feature on drug metabolism. You can find out more about drug metabolism on the website, at: https://www.bioanalysis-zone.com/2018/08/13/in-the-zone_inz_drug_metabolism/

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.

As part of our focus, we present this podcast where we talk to Mark Savage (Biotransformation and ADME Scientist, Unilabs, UK). Mark introduces what biotransformation is and the technologies used to characterize biotransformation. He discusses how software tools can address certain challenges and bring forward compounds from discovery to development.

At the FENS Forum of Neuroscience (7–11 July, Berlin, Germany), we had the pleasure of speaking with Irene Tracey, who is a Professor based at the University of Oxford (UK). Irene is also the Head of the Nuffield Department of Clinical Neurosciences (Oxford, UK), which includes a multidisciplinary taskforce working to understand neuroscience from a basic discovery perspective all the way through to clinical problems. Irene’s research particularly focuses on using neuroimaging to understand pain.

In this NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks to Irene to find out more about her talk at FENS, including significant breakthroughs within the field and if we could ever have one standardized measure of pain.

View more podcasts, news and exclusive interviews at www.neuro-central.com

The TAILORx study demonstrated that most women with a specific early-stage breast cancer and midrange score on the Oncotype Dx test do not need chemotherapy after surgery. These findings will spare thousands of women from the harmful effects of chemotherapy. We spoke with Andrew Paramore from Genomic Health (CA, USA)to discover insider details of the trial and what’s next for TAILORx.

Whilst at the Alzheimer’s Society Annual Conference (22–23 May, London, UK), we had the pleasure of speaking to Wendy Weidner, the Research and Policy Project Lead for Alzheimer’s Disease International, to hear more about her talk on ‘A world without dementia’.

In this #NCTalks podcast recorded at the event, Sharon Salt (Editor) speaks to Wendy to find out more about the work that Alzheimer’s Disease International is carrying out in terms of dementia globally, as well as the key challenges and biggest achievements involved to date.

View more podcasts, news and exclusive interviews at www.neuro-central.com